Science & Technology
Thu, July 14, 2011Wed, July 13, 2011Tue, July 12, 2011Mon, July 11, 2011Sun, July 10, 2011Sat, July 9, 2011Fri, July 8, 2011Thu, July 7, 2011Wed, July 6, 2011Tue, July 5, 2011Mon, July 4, 2011Sun, July 3, 2011Sat, July 2, 2011Fri, July 1, 2011Thu, June 30, 2011Wed, June 29, 2011Tue, June 28, 2011Mon, June 27, 2011SQI Diagnostics Announces Filing of Preliminary Prospectus
Published in Science and Technology on Wednesday, July 6th 2011 at 15:30 GMT by Market Wire
TORONTO, July 6, 2011 /CNW/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD), a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that it has filed and received a receipt for a preliminary short form base PREP prospectus with the Ontario Securities Commission and a registration statement on Form F-10 with the U.S. Securities and Exchange Commission in connection with a proposed offering of common shares.
Completion of the public offering is subject to and conditional upon the receipt of all necessary approvals, including regulatory approvals.
A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
FORWARD-LOOKING INFORMATION
This press release contains certain forward-looking statements, including, without limitation, statements containing the words "may", "shall", "expect", and other similar expressions which constitute "forward-looking information" within the meaning of applicable securities laws. Forward-looking statements reflect the Company's current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. The forward-looking statements in this press release include, without limitation, statements with respect to the completion of the proposed offering. These forward-looking statements involve risks and uncertainties including, but not limited to, risks related to market conditions for the offering, the failure to obtain necessary regulatory approvals, the failure to complete the Company's proposed acquisition of Scienion AG, exchange rates fluctuations and interest rates fluctuations, general economic and market segment conditions, and international risk and currency exchange. The forward-looking statements contained herein reflect the current views of the Company with respect to future events and are also subject to certain other risks and uncertainties and other risks detailed from time-to-time in the Company's ongoing filings with the securities regulatory authorities, which filings can be found at [ www.sedar.com ]. Actual results, events, and performance may differ materially from those contemplated in the Company's forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
